You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 0.0% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -13.8 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 0.0 | 0.0 |
| Price / Book value | 215.8 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2014-12-31 | n/a | -3.39 | -14.60p | -3.5 | 0.0 | n/a | n/a | 0.0% |
| 2015-12-31 | n/a | -8.63 | -9.50p | -22.9 | 0.0 | n/a | n/a | 0.0% |
| 2016-12-31 | n/a | -7.30 | -7.70p | -25.0 | 0.0 | n/a | n/a | 0.0% |
| 2017-12-31 | n/a | -8.26 | -6.40p | -21.7 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | n/a | -7.45 | -4.70p | -13.4 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | 0.00 | -10.03 | -6.72p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2020-12-31 | 0.00 | 0.00 | -8.57p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| Tiziana Life Sciences pleased with latest results from Milciclib trial Sharecast News | 14:02 |
|---|---|
| FDA asks Tiziana for more information on next 'foralumab' trial Sharecast News | 01 May |
| Tiziana completes patient enrolment in ongoing Milciclib study Sharecast News | 03 Dec |
| Phase 2a Clinical Data | 22-Jul-19 07:03 |
|---|---|
| Second Price Monitoring Extn | 28-Jun-19 16:41 |
| Price Monitoring Extension | 28-Jun-19 16:37 |
| Change of Adviser | 28-Jun-19 10:54 |
| Director/PDMR Shareholding | 25-Jun-19 07:07 |